High throughput inspecting

• US 20100294927A1
• Filed: 09/12/2006
• Published: 11/25/2010
• Est. Priority Date: 09/12/2005
• Status: Abandoned Application

• Current Assignee: Advanced Nanosolutions LLC, NanoInk, Inc.
• Original Assignee: Nanolnk, Inc.
• Inventors: Cruchon-Dupeyrat, Sylvain, Nelson, Michael, Rosner, Bjoern, Loiret-Bernal, Cedric
• Application Number:
  US11/519,199
• Publication Number:
  US 20100294927A1
• Time in Patent Office: Days
• US Class Current: 250/307
• CPC Class Codes: A61K 9/2072 characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms A61K9/0004, A61K9/0056, A61K9/0065 take precedence
• CPC Class Codes: G06Q 10/08 Logistics, e.g. warehousing, loading or distribution; Inventory or stock management
• CPC Class Codes: G16H 20/10 relating to drugs or medications, e.g. for ensuring correct administration to patients
• CPC Class Codes: G16H 70/40 relating to drugs, e.g. their side effects or intended usage

Abstract

The various embodiments provide methods and apparatus high-throughput reading and decoding of information-encoding features (especially identification features) on pharmaceutical compositions for the purpose of e.g. counterfeiting detection and inventory tracking/tracing. A preferred embodiment provides high-throughput imaging of regular arrays of pharmaceutical tablets with a scanning electron microscope. Another preferred embodiment provides video-rate scanning probe imaging of pharmaceutical compositions and especially atomic force microscopy imaging thereof.

Claims

1. A method comprising:

providing a plurality of unit pharmaceutical compositions each having a surface to be inspected potentially comprising identification features;

providing an inspection device which provides the inspection zone which allows inspecting the surface of the unit pharmaceutical compositions potentially comprising identification features;

providing an introducing device which introduces the unit pharmaceutical composition into the inspection zone before inspection, wherein the unit pharmaceutical compositions are positioned and aligned so their surfaces are properly exposed for inspection;

providing a withdrawing device which withdraws the unit pharmaceutical compositions from the inspection zone after inspection;

operating the inspection device, the introducing device, and the withdrawing device so that an inspection rate of unit pharmaceutical compositions is achieved of at least about 10 units per hour.

2. The method according to claim 1, wherein the inspection rate is at least about 100 units per hour.

3. The method according to claim 1, wherein the inspection rate is at least about 1,000 units per hour.

4. The method according to claim 1, wherein the inspection rate is at least about 5,000 units per hour.

5. The method according to claim 1, wherein the inspection device comprises a scanning electron microscope.

6. The method according to claim 1, wherein the introducing device comprises a robotic device.

7. The method according to claim 1, wherein the withdrawing device comprises a robotic device.

8. The method according to claim 1, wherein the inspecting device is adapted to comprise a tray provided from the introducing device which holds a plurality of unit pharmaceutical compositions, wherein each unit is disposed in a separate region on the tray.

9. The method according to claim 1, wherein the identification features are present and comprise micron scale features of at least about one micron in lateral dimension.

10. The method according to claim 1, wherein the identification features are present and comprise nanometer scale features of less than about 1,000 nm in lateral dimension.

11. The method according to claim 1, wherein the identification features are present and comprise an overt feature.

12. The method according to claim 1, wherein the identification features are present and comprise a covert feature.

13. The method according to claim 1, wherein the identification features are present and comprise an overt feature and a covert feature.

14. The method according to claim 1, further comprising the step of identifying whether the unit pharmaceutical composition is genuine, fake, or illegally traded.

15. The method according to claim 1, wherein the inspection device comprises a high resolution device able to resolve features of less than about 1,000 nm.

16. The method according to claim 1, wherein said inspecting comprises laser scanning, optical microscopy, confocal microscopy or profiling, scanning ion microscopy, scanning electron microscopy, stylus or interferometric profiling, scanning probe microscopy, video scanning probe microscopy, or a combination thereof.

17. The method according to claim 1, wherein the introducing device comprises a computer controlled, automated device.

18. The method according to claim 1, wherein the withdrawing device comprises a computer controlled, automated device.

19. The method according to claim 1, wherein the introducing device comprises a tray which holds a plurality of unit pharmaceutical compositions wherein each unit is disposed in separate regions on the tray for inspection as the tray is robotically introduced into the inspection device.

21. The method according to claim 1, wherein operating the introducing device comprises placing and orienting the unit pharmaceutical compositions on a tray.

23. The method according to claim 1, wherein the operating of the inspection device comprises extracting a pattern image from the unit pharmaceutical compositions.

24. The method according to claim 1, wherein the operating of the inspection device comprises inspecting under vacuum.

25. The method according to claim 1, wherein operating the introducing device comprises introducing the unit pharmaceuticals into a vacuum.

27. The method according to claim 1, further comprising dispensing the unit pharmaceuticals onto a holding device for the unit pharmaceuticals, wherein one unit pharmaceutical is disposed in a holding zone on the holding device.

28. The method according to claim 1, wherein the inspecting device comprises a motorized stage for aligning the unit pharmaceutical compositions with the inspection device during inspection.

29. The method according to claim 1, wherein the inspection device is operated to carry out inspection in at least two stages.

30. The method according to claim 1, wherein the operation of the inspecting device comprises comparing a measured identification feature with a design feature to determine a match.

31. The method according to claim 1, wherein the method further comprises the steps of inspecting and decoding micrometer or nanometer scale identification features.

32. The method according to claim 1, wherein the operating steps are computer controlled.

33. The method according to claim 1, further comprising computer analysis of the results of operating the inspection device.

34. The method according to claim 1, wherein the unit pharmaceuticals comprise at least two types of identification features, one smaller and one larger, which are designed to be inspected by different inspection methods.

35. The method according to claim 1, wherein the unit pharmaceutical compositions are metal coated over the identification features.

36. The method according to claim 1, wherein the operation of the inspection device comprises a location step and an imaging step.

37. The method according to claim 1, wherein the inspection device comprises a high resolutions scanning electron microscope and multiple vacuum chambers.

38. The method according to claim 1, wherein the unit pharmaceutical compositions comprise tablets.

39. The method according to claim 1, further comprising the step of identifying the unit pharmaceutical with use of a pharmaceutical data base comprising geographical distribution.

40. The method according to claim 1, wherein the unit pharmaceuticals comprise a coating to improve inspection.

55. The method according to claim 1, wherein the inspection device comprises a high resolution scanning electron microscope.

20. (canceled)

22. (canceled)

26. (canceled)

41. An apparatus comprising:

at least one scanning electron microscope (SEM) comprising a first vacuum chamber for SEM inspection, and at least one second vacuum chamber which can be evacuated and filled separately from the first vacuum chamber,

at least one first sample holder in the first vacuum chamber which is adapted to hold a plurality of sites for holding a plurality of unit pharmaceutical compositions to be inspected with the scanning electron microscope in the first vacuum chamber;

at least one second sample holder in the second vacuum chamber which is adapted to hold a plurality of sites for holding a plurality of unit pharmaceutical compositions to be inspected with the scanning electron microscope in the first vacuum chamber;

a sample holder transport device which transports the first sample holder from the first vacuum chamber to the second vacuum chamber; and

the second sample holder from the second vacuum chamber to the first vacuum chamber,

wherein the apparatus is adapted for a sample inspection rate of at least about 10 units per hour.

42. The apparatus according to claim 41, wherein the apparatus is adapted for a sample inspection rate of at least about 100 units per hour.

43. The apparatus according to claim 41, wherein the apparatus is adapted for a sample inspection rate of at least about 1,000 units per hour.

44. The apparatus according to claim 41, wherein the apparatus is adapted for a sample inspection rate of at least about 5,000 units per hour.

45. The apparatus according to claim 41, further comprising a computer to control the SEM inspection.

46. The apparatus according to claim 41, further comprising a robot to control the sample holder transport device.

47. The apparatus according to claim 41, further comprising an alignment device to facilitate SEM inspection.

48. A pharmaceutical composition comprising:

a unit pharmaceutical composition comprising surface identification features which are adapted to be imaged by scanning electron microscopy;

metallic coating over the identification features adapted to improve the imaging by scanning electron microscopy.

49. The pharmaceutical composition according to claim 48, wherein the composition is a tablet or capsule.

50. The pharmaceutical composition according to claim 48, wherein the identification features are imprinted identification features.

51. A method for inspecting unit pharmaceutical compositions comprising:

providing a plurality of unit pharmaceutical compositions each having a surface to be inspected potentially comprising at least two identification features on each unit pharmaceutical;

providing a computer controlled scanning electron microscope inspection device which provides an inspection zone which allows inspecting the surface of the unit pharmaceutical compositions potentially comprising identification features;

providing an automated introducing device which introduces the unit pharmaceutical composition into the inspection zone before inspection;

providing an automated withdrawing device which withdraws the unit pharmaceutical composition from the inspection zone after inspection;

operating the inspection device, the introducing device, and the withdrawing device so that an inspection rate of unit pharmaceutical compositions is achieved of at least about 10 units per hour.

52. The method according to claim 51, wherein the inspection rate is at least about 100 units per hour.

53. The method according to claim 51, wherein the inspection rate is at least about 1,000 units per hour.

54. The method according to claim 51, wherein the inspection rate is at least about 5,000 units per hour.

56. The method according to claim 51, wherein the introducing device comprises a robotic device.

57. The method according to claim 51, wherein the withdrawing device comprises a robotic device.

58. The method according to claim 51, wherein the inspecting device comprises a tray which holds a plurality of unit pharmaceutical compositions wherein each unit is disposed in separate regions on the tray for inspection.

59. The method according to claim 51, wherein the identification features comprise micron scale features of at least about one micron in lateral dimension.

60. The method according to claim 51, wherein the identification features comprise nanometer scale features of less than about 1,000 nm in lateral dimension.

61. The method according to claim 51, wherein the identification features comprise an overt feature.

62. The method according to claim 51, wherein the identification features comprise a covert feature.

63. The method according to claim 51, wherein the identification features comprise an overt feature and a covert feature.

64. The method according to claim 51, further comprising the step of identifying whether the unit pharmaceutical composition is genuine, fake, or illegally traded.

65. The method according to claim 51, wherein the inspection device comprises a high resolution scanning electron microscopy device able to resolve features of less than about 100 nm.

66. The method according to claim 51, wherein the inspection device comprises a scanning electron microscope adapted with a load lock.

67. The method according to claim 51, wherein the introducing device comprises a computer controlled, automated device synchronized with the inspecting device and the withdrawing device.

68. The method according to claim 51, wherein the withdrawing device comprises a computer controlled, automated device synchronized with the inspecting device and the introducing device.

69. The method according to claim 51, wherein the introducing device comprises a tray which holds a plurality of unit pharmaceutical compositions wherein each unit is disposed in separate regions on the tray for inspection.

70. The method according to claim 51, wherein the withdrawing device comprises a tray which holds a plurality of unit pharmaceutical compositions wherein each unit is disposed in separate regions on the tray for inspection.

71. The method according to claim 51, wherein operating the introducing device comprises placing and orienting the unit pharmaceutical compositions on a tray.

72. The method according to claim 51, wherein operating the introducing device comprises aligning the unit pharmaceutical compositions disposed on a tray.

73. The method according to claim 51, wherein the operating of the inspection device comprises extracting a pattern image from the unit pharmaceutical compositions.

74. The method according to claim 51, wherein the operating of the inspection device comprises inspecting under high vacuum.

75. The method according to claim 51, wherein operating the introducing device comprises introducing the unit pharmaceuticals into a vacuum.

76. The method according to claim 51, wherein operating the withdrawing device comprises withdrawing the unit pharmaceuticals from a vacuum.

77. The method according to claim 51, wherein the introducing device comprises a dispensing device which dispenses unit pharmaceuticals onto a holding device for the unit pharmaceuticals, wherein one unit pharmaceutical is disposed in one holding zone on the holding device.

78. The method according to claim 51, wherein the inspecting device comprises a motorized stage for aligning the unit pharmaceutical compositions with the inspection device during inspection.

79. The method according to claim 51, wherein the inspection device is operated to carry out inspection in two stages, one stage being an SEM stage and another stage being a non-SEM stage.

80. The method according to claim 51, wherein the operation of the inspecting device comprises comparing a measured identification feature with a design feature to determine a match.

81. The method according to claim 51, wherein the method is used for inspecting and decoding nanometer scale identification features.

82. The method according to claim 51, wherein the method is used for inspecting and decoding micrometer scale identification features.

83. The method according to claim 51, further comprising computer analysis of the results of operating the inspection device.

84. The method according to claim 51, wherein the unit pharmaceuticals comprise at least two types of identification features, one smaller and one larger, which are designed to be inspected by different inspection methods.

85. The method according to claim 51, wherein the unit pharmaceutical compositions are metal coated over the identification features.

86. The method according to claim 51, wherein the operation of the inspection device comprises a location step and an imaging step for the identification features.

87. The method according to claim 51, wherein the inspection device comprises a high resolutions scanning electron microscope and multiple vacuum chambers.

88. The method according to claim 51, wherein the unit pharmaceutical compositions comprise tablets.

89. The method according to claim 51, wherein the method is computer controlled and automated with robots.

90. The method according to claim 51, wherein the unit pharmaceuticals comprise a coating to improve inspection.

91. A method for inspecting unit pharmaceutical compositions in high throughput mode with scanning electron microscopy comprising the combination of steps:

providing a plurality of unit pharmaceutical compositions each having a surface to be inspected potentially comprising at least two identification features on each unit pharmaceutical and adapted for SEM inspection;

providing a computer controlled scanning electron microscope inspection device which provides an inspection zone which allows inspecting the surface of the unit pharmaceutical compositions potentially comprising identification features;

providing an automated, robotic introducing device which introduces the unit pharmaceutical composition into the inspection zone before inspection;

providing an automated, robotic withdrawing device which withdraws the unit pharmaceutical composition from the inspection zone after inspection;

operating the inspection device, the introducing device, and the withdrawing device so that an inspection rate of unit pharmaceutical compositions is achieved of at least about 10 units per hour;

processing inspection data collected from the inspection device to determine whether identification features are present or absent.

92. A method comprising:

providing a plurality of unit compositions or objects each having a surface to be inspected potentially comprising identification features;

providing an inspection device which provides the inspection zone which allows inspecting the surface of the unit compositions or objects potentially comprising identification features;

wherein the unit compositions or objects are positioned and aligned so their surfaces are properly exposed for inspection providing an introducing device which introduces the unit composition or object into the inspection zone before inspection;

providing a withdrawing device which withdraws the unit composition or object from the inspection zone after inspection;

operating the inspection device, the introducing device, and the withdrawing device so that an inspection rate of unit compositions or objects is achieved of at least about 10 units per hour.

93. A method comprising:

providing a plurality of unit pharmaceutical compositions each having a surface to be inspected comprising identification features;

providing an inspection device which provides the inspection zone which allows inspecting the surface of the unit pharmaceutical compositions comprising identification features;

providing an introducing device which introduces the unit pharmaceutical composition into the inspection zone before inspection;

wherein the unit pharmaceutical compositions are positioned and aligned so their surfaces are properly exposed for inspection,

providing a withdrawing device which withdraws the unit pharmaceutical composition from the inspection zone after inspection;

operating the inspection device, the introducing device, and the withdrawing device so that an inspection rate of unit pharmaceutical compositions is achieved of at least about 10 units per hour.